HeartSine® Technologies, Inc., a world leader in personal and public access defibrillators, today announced that William Samuel (Uel) McChesney is the new president of the company. McChesney succeeds Gregory Cash, who served as president and CEO for over four years.
McChesney is a 30-year veteran of financial, manufacturing and service in industries including healthcare and telecommunications in Europe, United States, Asia and Australia. His core competencies include operational experience in organic sales growth, international market penetration and product innovation programs, as well as, aggressive performance improvement and cost optimization strategies.
Most recently, McChesney served as director of Ferness Partners Ltd., a U.K. based business. Prior to that, he was CEO of Survitec Group Limited, a global leader supplying safety and survival equipment to commercial, defense and off-shore oil and gas markets.
“At a time when the market is flat, HeartSine is gaining significant market share as we post dramatic double-digit growth rates. This is a result of strategic positioning of our unique AED solution offerings for the treatment of Sudden Cardiac Arrest, such as the HeartSine samaritan® PAD 300P Public Access Defibrillator (PAD), as well as, stronger B2B alliances with partners,” said Bernard Collins, Chairman of the Board, HeartSine Technologies, Inc.
“Uel brings the strategic and operational expertise we need to sustain our high growth rates and further increase our growing share of the Automated External Defibrillator market. He’ll be based out of our Belfast office which is mission-critical to us as we build a high-growth customer-focused workforce,” said Collins.
HeartSine’s significant investments in research and development and innovative culture have produced industry advanced technology and state-of-the-art components which not only meet but exceed AED clinical efficacy standards. This culture empowers HeartSine to provide end users with leading life-saving technology, exceptional product reliability and with HeartSine’s new ten-year warranty, the lowest cost of ownership.
About HeartSine Technologies
A world leader in personal and public access defibrillators, HeartSine’s mission is to advance the deployment of lifesaving defibrillation therapy in non-traditional areas of care. HeartSine® samaritan® PAD (Public Access Defibrillator) is the only medical device specifically designed for public access use to administer lifesaving treatment for Sudden Cardiac Arrest. It’s lifesaving, pure and simple.
For more information, please contact [email protected], call (866) 478-7463, ext. 112, or visit www.heartsine.com.
